NM_001001331.4:c.2703+9G>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001001331.4(ATP2B2):​c.2703+9G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.434 in 1,613,588 control chromosomes in the GnomAD database, including 156,882 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 11630 hom., cov: 33)
Exomes 𝑓: 0.44 ( 145252 hom. )

Consequence

ATP2B2
NM_001001331.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.497

Publications

11 publications found
Variant links:
Genes affected
ATP2B2 (HGNC:815): (ATPase plasma membrane Ca2+ transporting 2) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 2. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ATP2B2 Gene-Disease associations (from GenCC):
  • hearing loss, autosomal dominant 82
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal recessive nonsyndromic hearing loss 12
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 3-10345375-C-A is Benign according to our data. Variant chr3-10345375-C-A is described in ClinVar as Benign. ClinVar VariationId is 1247918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.528 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP2B2NM_001001331.4 linkc.2703+9G>T intron_variant Intron 18 of 22 ENST00000360273.7 NP_001001331.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP2B2ENST00000360273.7 linkc.2703+9G>T intron_variant Intron 18 of 22 5 NM_001001331.4 ENSP00000353414.2

Frequencies

GnomAD3 genomes
AF:
0.366
AC:
55629
AN:
152018
Hom.:
11635
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.152
Gnomad AMI
AF:
0.517
Gnomad AMR
AF:
0.508
Gnomad ASJ
AF:
0.361
Gnomad EAS
AF:
0.517
Gnomad SAS
AF:
0.547
Gnomad FIN
AF:
0.430
Gnomad MID
AF:
0.459
Gnomad NFE
AF:
0.427
Gnomad OTH
AF:
0.390
GnomAD2 exomes
AF:
0.451
AC:
112944
AN:
250682
AF XY:
0.455
show subpopulations
Gnomad AFR exome
AF:
0.142
Gnomad AMR exome
AF:
0.593
Gnomad ASJ exome
AF:
0.375
Gnomad EAS exome
AF:
0.507
Gnomad FIN exome
AF:
0.428
Gnomad NFE exome
AF:
0.424
Gnomad OTH exome
AF:
0.438
GnomAD4 exome
AF:
0.441
AC:
643989
AN:
1461450
Hom.:
145252
Cov.:
48
AF XY:
0.444
AC XY:
322761
AN XY:
727028
show subpopulations
African (AFR)
AF:
0.144
AC:
4814
AN:
33476
American (AMR)
AF:
0.582
AC:
26004
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.363
AC:
9495
AN:
26130
East Asian (EAS)
AF:
0.561
AC:
22287
AN:
39694
South Asian (SAS)
AF:
0.559
AC:
48238
AN:
86242
European-Finnish (FIN)
AF:
0.440
AC:
23488
AN:
53380
Middle Eastern (MID)
AF:
0.449
AC:
2588
AN:
5762
European-Non Finnish (NFE)
AF:
0.433
AC:
481722
AN:
1111684
Other (OTH)
AF:
0.420
AC:
25353
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
19119
38238
57356
76475
95594
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14794
29588
44382
59176
73970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.366
AC:
55633
AN:
152138
Hom.:
11630
Cov.:
33
AF XY:
0.373
AC XY:
27764
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.152
AC:
6302
AN:
41544
American (AMR)
AF:
0.508
AC:
7764
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.361
AC:
1251
AN:
3468
East Asian (EAS)
AF:
0.517
AC:
2659
AN:
5142
South Asian (SAS)
AF:
0.546
AC:
2633
AN:
4826
European-Finnish (FIN)
AF:
0.430
AC:
4555
AN:
10596
Middle Eastern (MID)
AF:
0.469
AC:
138
AN:
294
European-Non Finnish (NFE)
AF:
0.427
AC:
29045
AN:
67950
Other (OTH)
AF:
0.386
AC:
817
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1714
3427
5141
6854
8568
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
534
1068
1602
2136
2670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.392
Hom.:
6991
Bravo
AF:
0.358
EpiCase
AF:
0.423
EpiControl
AF:
0.420

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 29, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
3.4
DANN
Benign
0.78
PhyloP100
-0.50
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs241509; hg19: chr3-10387059; COSMIC: COSV59497093; API